In this study, 2% of whole samples exhibit a mutation on ARHGAP35 gene and this mutational status appears significant for five tumor types: Endometrial tumors (14%), lung squamous cell carcinoma (5%), lung adenocarcinoma (3%), head and neck cancer (3%), and kidney clear cell carcinoma (1%) [82]. The gene discussed is ARHGAP35; the disease is neoplasm.